Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02543723 · ClinicalTrials.gov registry record · NA

Telehealth-based Strategies to Increase Oral Chemotherapeutic Agent Medication Adherence

A NA study, sponsored by East Carolina University.

Completed
Registry status
NA
Development phase
128
Enrollment target

NCT02543723: Completed NA study, sponsored by East Carolina University.

NCT02543723 is a NA study that has completed, run by East Carolina University. The registered enrollment target is 128 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02543723, a NA study, has completed, sponsored by East Carolina University.

COMPLETED
Registry status
NA
Development phase
128 participants
Enrollment target

Study Summary

Oral chemotherapeutic agents (OCAs) are increasingly being used as an alternative to traditional intravenous chemotherapy, and factors promoting this trend include increased survival times requiring long-term therapy, acceptability among patients, convenience, and cost savings due to reduced hospital time. Although OCAs are commonly preferred by patients, adherence to these medications vary. Suboptimal medication adherence leads to loss of treatment efficacy, increased toxicity, and increased health care costs. Thus, it is critical to develop and test interventions that effectively improve adherence to OCAs. Although the medication adherence literature has been criticized for methodological issues, some components of interventions have had promising results on adherence such as electronic monitored adherence feedback, cognitive-education, nurse-based interventions, and technology-based or telehealth strategies. The investigators propose to unify components of these effective approaches in a novel way to assess the efficacy and feasibility of two telehealth-based strategies (electronic medication-event monitoring with feedback and tailored nurse coaching which includes cognitive-education) in an effort increase OCA adherence among cancer patients who are at high-risk for non-adherence in rural eastern North Carolina.

Primary Outcome

The participant's cancer medication adherence was taken at baseline and within a 6-month follow-up period. We measured the participant's self-efficacy with medication adherence increase with their OCAs using the SEAMS scale. SEAMS Scale: 21 items scale, ranges from 21-63, higher scores indicate higher level of self-efficacy for medication adherence.

Interventions

  • BEHAVIORAL Nurse Coach Intervention

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2015-11-15
Est. Completion 2020-12-31
Phase NA
East Carolina University

58 total trials

What the finished NCT02543723 record still lists

NCT02543723 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 1 intervention - of which Nurse Coach Intervention is the first listed.

NCT02543723 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02543723 about?

NCT02543723 is a clinical study titled "Telehealth-based Strategies to Increase Oral Chemotherapeutic Agent Medication Adherence". Oral chemotherapeutic agents (OCAs) are increasingly being used as an alternative to traditional intravenous chemotherapy, and factors promoting this trend include increased survival times requiring long-term therapy, acceptability among patients, convenience, and cost savings due to reduced hospita...

What is the current status of trial NCT02543723?

This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2015-11-15. Estimated completion is 2020-12-31.

What interventions are being tested in trial NCT02543723?

The interventions under investigation include: Nurse Coach Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02543723?

This trial is sponsored by East Carolina University, which has 58 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02543723's enrollment target sits among peer trials

128 744th of 2000 higher than 1,252 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02870738 · 128 participants · Phase 2

    Bladder Directed vs. Pelvic Floor Therapy in IC/BPS

  • NCT03294460 · 128 participants · Phase 1

    Nicotinic Receptor Genetic Variation and Alcohol Reward

  • NCT04149977 · 128 participants · NA

    Blood Flow Restriction Therapy in Lower Limb Extensor Injuries

  • NCT04373057 · 128 participants · Phase 1

    Prebiotic Galacto-oligosaccharide and Acute GVHD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02543723, the US trial registry maintained by the National Library of Medicine. NCT02543723 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.